DARRYL EINHORN: Open Payments
NPI 1679917314 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 35 payments from 11 companies in 2025. Trend: 2023 $674 · 2024 $760 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $190 |
| BIOTRONIK NRO, Inc. | 9 | $169 |
| Boston Scientific Corporation | 3 | $86 |
| Abbott Laboratories | 2 | $45 |
| Medtronic, Inc. | 2 | $36 |
| Globus Medical, Inc. | 1 | $35 |
| Fidia Pharma USA Inc. | 1 | $26 |
| IBSA Pharma Inc. | 1 | $24 |
| SI-BONE, INC. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Belbuca, Prospera, WaveWriter Alpha Prime 16, INCEPTIV, Senza, EXCLAIM, HYMOVIS, Tirosint.
Industry payments across VA — which companies pay providers there.
